TRANSGENE SA (TRGNF:OTCMKTS)
$0 None (None%)
Analysed TRANSGENE SA (TRGNF:OTCMKTS) News Sources
Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications
02-09-2026
yahoo.com
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
08-09-2026
yahoo.com
Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field
24-09-2026
yahoo.com
Transgene to Participate in Investor Access
01-10-2026
yahoo.com
Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026
05-10-2026
yahoo.com
What is the current price of TRANSGENE SA (TRGNF:OTCMKTS)?
The current price of TRANSGENE SA (TRGNF:OTCMKTS) is $0.
TRANSGENE SA (TRGNF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TRANSGENE SA (TRGNF:OTCMKTS) since the previous trading day is $None.
TRANSGENE SA (TRGNF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TRANSGENE SA (TRGNF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for TRANSGENE SA (TRGNF:OTCMKTS)?
The most recent average sentiment score for TRANSGENE SA (TRGNF:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for TRANSGENE SA (TRGNF:OTCMKTS)?
The most recent sentiment for TRANSGENE SA (TRGNF:OTCMKTS) is .
SEC-8K** Filing Available For TRANSGENE SA (TRGNF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.